LM FUNDING AMERICA INC (LMFA)

US5020745031 - Common Stock

2.36  -0.01 (-0.42%)

Premarket: 2.71 +0.35 (+14.83%)

Fundamental Rating

2

LMFA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 102 industry peers in the Financial Services industry. The financial health of LMFA is average, but there are quite some concerns on its profitability. While showing a medium growth rate, LMFA is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

LMFA had negative earnings in the past year.
LMFA had a negative operating cash flow in the past year.
LMFA had negative earnings in 4 of the past 5 years.
LMFA had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -42.29%, LMFA is not doing good in the industry: 92.16% of the companies in the same industry are doing better.
LMFA has a worse Return On Equity (-44.07%) than 88.24% of its industry peers.
Industry RankSector Rank
ROA -42.29%
ROE -44.07%
ROIC N/A
ROA(3y)-29.86%
ROA(5y)-32.33%
ROE(3y)-31.89%
ROE(5y)-47.39%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LMFA has a worse Gross Margin (13.23%) than 61.76% of its industry peers.
LMFA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LMFA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-26.28%

5

2. Health

2.1 Basic Checks

LMFA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LMFA has less shares outstanding
The number of shares outstanding for LMFA has been increased compared to 5 years ago.
Compared to 1 year ago, LMFA has a worse debt to assets ratio.

2.2 Solvency

LMFA has an Altman-Z score of -0.27. This is a bad value and indicates that LMFA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.27, LMFA is doing worse than 68.63% of the companies in the same industry.
LMFA has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.02, LMFA belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -0.27
ROIC/WACCN/A
WACC8.67%

2.3 Liquidity

LMFA has a Current Ratio of 3.67. This indicates that LMFA is financially healthy and has no problem in meeting its short term obligations.
LMFA has a better Current ratio (3.67) than 89.22% of its industry peers.
LMFA has a Quick Ratio of 3.67. This indicates that LMFA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.67, LMFA belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.67
Quick Ratio 3.67

4

3. Growth

3.1 Past

The earnings per share for LMFA have decreased strongly by -50.60% in the last year.
LMFA shows a strong growth in Revenue. In the last year, the Revenue has grown by 673.18%.
Measured over the past years, LMFA shows a very strong growth in Revenue. The Revenue has been growing by 30.82% on average per year.
EPS 1Y (TTM)-50.6%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q55.63%
Revenue 1Y (TTM)673.18%
Revenue growth 3Y117.64%
Revenue growth 5Y30.82%
Revenue growth Q2Q262.33%

3.2 Future

The Earnings Per Share is expected to grow by 34.14% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -20.00% on average over the next years. This is quite bad
EPS Next Y21.88%
EPS Next 2Y34.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.6%
Revenue Next 2Y-20%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LMFA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LMFA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LMFA's earnings are expected to grow with 34.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.14%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LMFA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LM FUNDING AMERICA INC

NASDAQ:LMFA (5/15/2024, 7:00:00 PM)

Premarket: 2.71 +0.35 (+14.83%)

2.36

-0.01 (-0.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.88M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.29%
ROE -44.07%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 13.23%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.67
Quick Ratio 3.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-50.6%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y21.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)673.18%
Revenue growth 3Y117.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y